3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

2. Globus Medical, Inc. (NYSE:GMED)

Stake Value of Consonance Capital Management: $45,137,000

Percentage of Consonance Capital Management’s 13F Portfolio: 24.7%

Number of Hedge Fund Holders: 37

Globus Medical, Inc. (NYSE:GMED) is a healthcare equipment company that manufactures products for patients with musculoskeletal disorders. By the end of the third quarter of 2021, 37 hedge funds held stakes in Globus Medical, Inc. (NYSE:GMED). This is compared to 35 positions in the second quarter of 2021. The total value of these stakes was $266.75 million, of which $45.13 million was the stake of Mitchell Blutt’s Consonance Capital Management.

This January, UBS analyst Matthew Taylor reiterated his Buy rating and $91 price target on the stock for Globus Medical, Inc. (NYSE:GMED).